2082eTiP COPERNICUS: A multinational pragmatic phase II trial of subcutaneous (SC) amivantamab (Ami) in common EGFR-mutated (cEGFRm) NSCLC.
Saved in:
| Title: | 2082eTiP COPERNICUS: A multinational pragmatic phase II trial of subcutaneous (SC) amivantamab (Ami) in common EGFR-mutated (cEGFRm) NSCLC. |
|---|---|
| Authors: | Halmos, B.1 (AUTHOR), Florez, N.2 (AUTHOR), Goldberg, S.B.3 (AUTHOR), Iams, W.4 (AUTHOR), Le, X.5 (AUTHOR), Leal, T.A.6 (AUTHOR), Nguyen, D.7 (AUTHOR), Raez, L.E.8 (AUTHOR), Riess, J.W.9 (AUTHOR), Sabari, J.10 (AUTHOR), Bjork, D.11 (AUTHOR), Stigger, N.12 (AUTHOR), Minchom, A.R.13 (AUTHOR), Xia, K.14 (AUTHOR), Cifuentes, P.15 (AUTHOR), Shanoon, F.15 (AUTHOR), Penton, J.16 (AUTHOR), Hulten, A.17 (AUTHOR), Johnson, M.L.18 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1173-S1173. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189420482 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 2082eTiP COPERNICUS: A multinational pragmatic phase II trial of subcutaneous (SC) amivantamab (Ami) in common EGFR-mutated (cEGFRm) NSCLC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Halmos%2C+B%2E%22">Halmos, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Florez%2C+N%2E%22">Florez, N.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goldberg%2C+S%2EB%2E%22">Goldberg, S.B.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Iams%2C+W%2E%22">Iams, W.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Le%2C+X%2E%22">Le, X.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leal%2C+T%2EA%2E%22">Leal, T.A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nguyen%2C+D%2E%22">Nguyen, D.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Raez%2C+L%2EE%2E%22">Raez, L.E.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Riess%2C+J%2EW%2E%22">Riess, J.W.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sabari%2C+J%2E%22">Sabari, J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bjork%2C+D%2E%22">Bjork, D.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stigger%2C+N%2E%22">Stigger, N.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Minchom%2C+A%2ER%2E%22">Minchom, A.R.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xia%2C+K%2E%22">Xia, K.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cifuentes%2C+P%2E%22">Cifuentes, P.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shanoon%2C+F%2E%22">Shanoon, F.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Penton%2C+J%2E%22">Penton, J.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hulten%2C+A%2E%22">Hulten, A.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Johnson%2C+M%2EL%2E%22">Johnson, M.L.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS1173-S1173. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189420482 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.2703 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1173 Titles: – TitleFull: 2082eTiP COPERNICUS: A multinational pragmatic phase II trial of subcutaneous (SC) amivantamab (Ami) in common EGFR-mutated (cEGFRm) NSCLC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Halmos, B. – PersonEntity: Name: NameFull: Florez, N. – PersonEntity: Name: NameFull: Goldberg, S.B. – PersonEntity: Name: NameFull: Iams, W. – PersonEntity: Name: NameFull: Le, X. – PersonEntity: Name: NameFull: Leal, T.A. – PersonEntity: Name: NameFull: Nguyen, D. – PersonEntity: Name: NameFull: Raez, L.E. – PersonEntity: Name: NameFull: Riess, J.W. – PersonEntity: Name: NameFull: Sabari, J. – PersonEntity: Name: NameFull: Bjork, D. – PersonEntity: Name: NameFull: Stigger, N. – PersonEntity: Name: NameFull: Minchom, A.R. – PersonEntity: Name: NameFull: Xia, K. – PersonEntity: Name: NameFull: Cifuentes, P. – PersonEntity: Name: NameFull: Shanoon, F. – PersonEntity: Name: NameFull: Penton, J. – PersonEntity: Name: NameFull: Hulten, A. – PersonEntity: Name: NameFull: Johnson, M.L. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |